Stay updated on Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial
Sign up to get notified when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.

Latest updates to the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe history now includes a new revision entry for v3.6.6, replacing the previous v3.6.5. This indicates an update to the study record's documentation rather than any substantive changes to the study data.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page history now shows Revision: v3.6.5 as the current revision, replacing Revision: v3.6.4, signifying a new build/version of the page has been recorded.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page shows a new Revision: v3.6.4, replacing the previous v3.6.3, indicating a deployment or platform update. The underlying study history content remains unchanged.SummaryDifference0.1%

- Check70 days agoChange DetectedFooter revision tag updated from v3.6.2 to v3.6.3, signaling a minor platform update. No study content or user-facing information was changed.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2 on the page. This indicates a new site revision/version applied to the record history page.SummaryDifference0.1%

- Check92 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and the study record version updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.